Verweij J - Search Results

1

Differential modulation of cisplatin accumulation in leukocytes and tumor cell lines by the paclitaxel vehicle Cremophor EL.

de Vos AI, Nooter K, Verweij J, Loos WJ, Brouwer E, de Bruijn P, Ruijgrok EJ, van der Burg ME, Stoter G, Sparreboom A. de Vos AI, et al. Among authors: verweij j. Ann Oncol. 1997 Nov;8(11):1145-50. doi: 10.1023/a:1008215720081. Ann Oncol. 1997. PMID: 9426335 Free article.

2

Influence of Cremophor El on the bioavailability of intraperitoneal paclitaxel.

Gelderblom H, Verweij J, van Zomeren DM, Buijs D, Ouwens L, Nooter K, Stoter G, Sparreboom A. Gelderblom H, et al. Among authors: verweij j. Clin Cancer Res. 2002 Apr;8(4):1237-41. Clin Cancer Res. 2002. PMID: 11948138 Clinical Trial.

3

Preclinical evaluation of alternative pharmaceutical delivery vehicles for paclitaxel.

Loos WJ, Szebeni J, ten Tije AJ, Verweij J, van Zomeren DM, Chung KN, Nooter K, Stoter G, Sparreboom A. Loos WJ, et al. Among authors: verweij j. Anticancer Drugs. 2002 Aug;13(7):767-75. doi: 10.1097/00001813-200208000-00012. Anticancer Drugs. 2002. PMID: 12187334

4

Randomized cross-over evaluation of body-surface area-based dosing versus flat-fixed dosing of paclitaxel.

Smorenburg CH, Sparreboom A, Bontenbal M, Stoter G, Nooter K, Verweij J. Smorenburg CH, et al. Among authors: verweij j. J Clin Oncol. 2003 Jan 15;21(2):197-202. doi: 10.1200/JCO.2003.01.058. J Clin Oncol. 2003. PMID: 12525510 Clinical Trial.

5

Pharmacological effects of formulation vehicles : implications for cancer chemotherapy.

ten Tije AJ, Verweij J, Loos WJ, Sparreboom A. ten Tije AJ, et al. Among authors: verweij j. Clin Pharmacokinet. 2003;42(7):665-85. doi: 10.2165/00003088-200342070-00005. Clin Pharmacokinet. 2003. PMID: 12844327 Review.

6

Evaluation of an alternate dosing strategy for cisplatin in patients with extreme body surface area values.

Loos WJ, de Jongh FE, Sparreboom A, de Wit R, van Boven-van Zomeren DM, Stoter G, Nooter K, Verweij J. Loos WJ, et al. Among authors: verweij j. J Clin Oncol. 2006 Apr 1;24(10):1499-506. doi: 10.1200/JCO.2005.03.0056. J Clin Oncol. 2006. PMID: 16574999 Clinical Trial.

7

Frequent administration of Dabis Maleate, a phase I study.

Verweij J, Planting AS, de Boer M, van der Burg ME, Stoter G. Verweij J, et al. Ann Oncol. 1992 Mar;3(3):241-2. doi: 10.1093/oxfordjournals.annonc.a058161. Ann Oncol. 1992. PMID: 1586625 Free article. Clinical Trial.

8

Phase II study of combining vinblastine and cyclosporin-A to circumvent multidrug resistance in renal cell cancer.

Rodenburg CJ, Nooter K, Herweijer H, Seynaeve C, Oosterom R, Stoter G, Verweij J. Rodenburg CJ, et al. Among authors: verweij j. Ann Oncol. 1991 Apr;2(4):305-6. doi: 10.1093/oxfordjournals.annonc.a057941. Ann Oncol. 1991. PMID: 1868026 Free article. Clinical Trial. No abstract available.

9

Phase II study of cisplatin plus 24-hour infusion of ifosfamide in advanced malignant melanoma.

Verweij J, Planting AS, van der Gaast A, Stoter G. Verweij J, et al. Ann Oncol. 1990;1(1):77-8. doi: 10.1093/oxfordjournals.annonc.a057679. Ann Oncol. 1990. PMID: 2078488 Free article.

10

Phase I study of weekly high-dose cisplatin combined with long-term oral etoposide in advanced solid tumors.

Planting AS, van der Burg ME, de Boer-Dennert M, Stoter G, Verweij J. Planting AS, et al. Among authors: verweij j. Ann Oncol. 1995 Feb;6(2):190-2. doi: 10.1093/oxfordjournals.annonc.a059117. Ann Oncol. 1995. PMID: 7786826 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

929 results

Search Page

Filters